Magnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery

Simple item page
dc.contributor.authorCristian F. Rodríguez
dc.contributor.authorPaula Guzmán-Sastoque
dc.contributor.authorAlan Santacruz-Belalcazar
dc.contributor.authorC. Jorge Laureano Moya Rodríguez
dc.contributor.authorPaula Villamarin
dc.contributor.authorLuis H. Reyes
dc.contributor.authorJuan C. Cruz
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:03:54Z
dc.date.available2026-03-22T21:03:54Z
dc.date.issued2025
dc.descriptionCitaciones: 6
dc.description.abstractWhile magnetoliposomes show remarkable therapeutic versatility, their clinical translation requires addressing biocompatibility concerns, manufacturing scalability, and regulatory hurdles. Integration with artificial intelligence, organ-on-chip technologies, and personalized medicine approaches will likely accelerate their development toward clinical reality, potentially revolutionizing treatment paradigms for complex diseases through tailored therapeutic interventions.
dc.identifier.doi10.1080/17425247.2025.2506829
dc.identifier.urihttps://doi.org/10.1080/17425247.2025.2506829
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85718
dc.language.isoen
dc.publisherTaylor & Francis
dc.relation.ispartofExpert Opinion on Drug Delivery
dc.sourceUniversidad de Los Andes
dc.subjectNanomedicine
dc.subjectDrug delivery
dc.subjectNanotechnology
dc.subjectDrug
dc.subjectGene delivery
dc.subjectMaterials science
dc.subjectPeptide
dc.subjectTargeted drug delivery
dc.subjectPharmacology
dc.subjectMedicine
dc.titleMagnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery
dc.typereview

Files

Collections

Artículo Científico Publicado